Safety and efficacy of aspirin combined with warfarin in the treatment of coronary heart disease and atrial fibrillation
Pan Jian-shen
Abstract
Pan Jian-shen
Abstract
Objective To observe the safety and efficacy of aspirin combined with warfarin in the treatment of coronary heart disease and atrial fibrillation. Methods 46 cases of patients with coronary heart disease and atrial fibrillation in our department from August 2012 to August 2013 were divided into observation group and control group,23cases in each group. The observation group received aspirin combined with warfarin treatment,the control group received warfarin treatment only. The incidence of thromboembolism,bleeding,and renal function of the two groups were compared. Results The incidene of thromboembolism,bleeding,and renal function changes had no significant differences between observation group and control group( P 0. 05). Conclusion Aspirin combined with warfarin treatment for coronary heart disease and atrial fibrillation has lower incidence of thrombosis,bleeding,but has no significant difference compared with warfarin alone.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the safety and efficacy of aspirin combined with warfarin in the treatment of coronary heart disease and atrial fibrillation. Methods 46 cases of patients with coronary heart disease and atrial fibrillation in our department from August 2012 to August 2013 were divided into observation group and control group,23cases in each group. The observation group received aspirin combined with warfarin treatment,the control group received warfarin treatment only. The incidence of thromboembolism,bleeding,and renal function of the two groups were compared. Results The incidene of thromboembolism,bleeding,and renal function changes had no significant differences between observation group and control group( P 0. 05). Conclusion Aspirin combined with warfarin treatment for coronary heart disease and atrial fibrillation has lower incidence of thrombosis,bleeding,but has no significant difference compared with warfarin alone.
Key concepts: Medicine, Warfarin, Aspirin, Atrial fibrillation, Internal medicine, Cardiology, Incidence (geometry), Coronary heart disease